-Frontline Members of denotified, nomadic and semi-nomadic tribes, treated as criminal tribes by the colonial rulers, have no place to call their own and no land, no rights, and no support from the government.  Emaciated, eyes sunken deep into sockets, skin hanging loose, almost gasping for breath, Indro Devi and Sarvnath, a couple in their eighties, lie on polythene sheets in an 8×10 square-foot tent made of rags, by a stinking nullah...

-The Indian Express Mining in India has come a long way in the last 50 years or so. From the Industrial Policy Resolution of 1957 to the National Mineral Policy (NMP) of 1993, and now to the NMP of 2008, it has shown a progressive shift towards bringing the private sector into exploration, mining and downstream value addition. However, the regulatory systems perhaps never managed to keep pace with developments on...

-The Hindu The government’s ill-conceived urban development schemes are threatening the future of Delhi The Delhi Urban Arts Commission was constituted by an Act of Parliament in 1972 with the sole intention of acting as a supra urban body to guide the future development of Delhi. After 40 years of its existence, chaired by a galaxy of bureaucrats and, more recently, famous architects, it is still difficult to evaluate whether it has...

-The Hindu Jamia Teachers’ report reveals framing of several innocents The Jamia Teachers’ Solidarity Association has in its latest report titled “Framed, Damned, Acquitted: Dossiers of a Very Special Cell” chronicled 16 cases in which most of those arrested were accused of being operatives and agents of various terrorist organisations, only to be acquitted later of all charges by the courts. In some of these cases the courts even held the police...

-The Economic Times MUMBAI: In a victory to generic drugmakers, the Intellectual Property Appellate Board (IPAB) of Chennai has dismissed German pharma major Bayer's plea, seeking a stay on the Compulsory Licence issued to Hyderabad-based drugmaker Natco. The Compulsory Licence (CL) issued by the Controller of Patents in March this year allowed Natco to make and sell a generic version of Nexavar - used for treating liver and kidney cancer - at...